• Spleen­lab devel­ops AI soft­ware for the safe autonomous flight of drones and air taxis
• bm|t, APEX Ven­tures and a busi­ness angel have invested a seven-fig­ure sum in the Thürin­gen high- tech AI com­pany Spleen­lab GmbH
• This first financ­ing round will fund Spleenlab´s growth and mar­ket development
• The company´s loca­tion in Thürin­gen and rural areas are dri­vers of its innovation
• BayStartUP sup­ported Spleen­lab in approach­ing suit­able investors

Spleen­lab and bm|t, together with APEX Ven­tures and a busi­ness angel, are jointly bring­ing the future of mobil­ity to East Thürin­gen. With the help of Arti­fi­cial Intel­li­gence, Spleen­lab will enable the safe autonomous flight of drones and air taxis in the future. The aim of the seven-fig­ure invest­ment is the fur­ther expan­sion of the com­pany and its suc­cess­ful estab­lish­ment in a promis­ing mar­ket. The financ­ing round was also made pos­si­ble by the sup­port of BayStartUP’s investor net­work. Inno­v­a­tive Tech­nol­ogy Spleen­lab GmbH devel­ops AI soft­ware for the autonomous flight of drones and air taxis. The fusion of dif­fer­ent sen­sors such as cam­eras, laser scan­ners and radars with AI cre­ates highly effi­cient tech­nol­ogy appli­ca­tions. These capa­bil­i­ties can be used not only for fly­ing, but also for the inspec­tion and mon­i­tor­ing of indus­trial plants, the pre­cise mon­i­tor­ing of forests, agri­cul­tural land and crit­i­cal infra­struc­ture, the safe trans­port of sen­si­tive goods or the pre­cise track­ing of miss­ing per­sons and acci­dent vic­tims. «Our aim is to develop tai­lor-made AI solu­tions for our cus­tomers and at the same time to strengthen con­fi­dence in this key future tech­nol­ogy in Ger­many, Europe and beyond,» said Tobias Rüdi­ger, Head of Oper­a­tions & Finance. Machine learn­ing and new forms of mobil­ity Get­ting drones and air taxis safely into the air with­out pilots is Spleenlab´s long-term goal. How­ever, the com­pany is not lim­ited to only these mar­kets, because the key to new mobil­ity con­cepts lies in machine learn­ing, a spe­cial form of arti­fi­cial intel­li­gence, as Dr. Ste­fan Milz, Head of Research & Devel­op­ment, empha­sized: «Machine learn­ing is a highly com­plex tech­nol­ogy area. The algo­rithms we have devel­oped are intended to enable vehi­cles and machines of all kinds to make inde­pen­dent deci­sions and thus carry out time-con­sum­ing processes faster, more pre­cisely and, above all, more cost-effec­tively than ever before.» Rural areas as dri­ver of inno­va­tion The suc­cess­fully com­pleted invest­ment round strength­ens Thürin­gen as a busi­ness loca­tion and shows that young high-tech firms are not only at home in met­ro­pol­i­tan areas. Sebas­t­ian Süß, Head of Mar­ket­ing & Sales stated: «We delib­er­ately chose our home region as a busi­ness loca­tion, because we believe that the devel­op­ment oppor­tu­ni­ties in rural areas in par­tic­u­lar are greater than in densely pop­u­lated met­ro­pol­i­tan areas. The prox­im­ity to var­i­ous uni­ver­si­ties and eco­nomic clus­ters in the region, such as Jena, Ilme­nau and Chem­nitz, offers an ideal envi­ron­ment for our growth.” “We are there­fore even more pleased to have a strong region­ally rooted part­ner, bm|t, at our side who will, together with the tech­no­log­i­cal expe­ri­ence of APEX Ven­tures, sup­port our future path,» added co-founder Tobias Rüdi­ger. Invest­ing in a ground­break­ing indus­try of the future The engage­ment of bm|t together with APEX Ven­tures and a busi­ness angel is a con­scious step into a dynamic dig­i­tal­ized future. «With Spleen­lab, we are pleased to have a highly inno­v­a­tive Thürin­gen high-tech com­pany on board and to be able to sup­port its growth», said Katja Butz­mann, Senior Invest­ment Man­ager, bm|t.  Andreas Riegler, found­ing part­ner of APEX Ven­tures added: «We are con­vinced of the idea and the deep know-how of Spleen­lab and together we aim to estab­lish the next mar­ket leader for AI solu­tions in Ger­many and Europe». The Bavar­ian start-up net­work BayStartUP pro­vided valu­able sup­port in prepar­ing this financ­ing round by approach­ing investors that are a per­fect strate­gic fit for Spleenlab’s busi­ness model.